The classic mode of G protein-coupled receptor (GPCR)-mediated transactivation of the receptor tyrosine kinase epidermal growth factor receptor (EGFR) transactivation 
| INTRODUCTION
G-protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) comprise a large proportion of cell-surface receptors that sense and respond to extracellular stimuli employing distinct signal transducers to execute downstream signaling.
1,2 A point of convergence between GPCRs and RTKs at the cell surface is the phenomenon of GPCR-induced RTK transactivation. 3, 4 The first identified and best-studied example is EGFR transactivation. 5 Most often, this is achieved by activation of cell-surface matrix metalloproteases (MMPs), which cleave the ectodomain of membrane-anchored EGFR ligands to release soluble ligands that then bind and activate EGFRs. 6 A number of GPCR signal transducers have been implicated in EGFR transactivation via MMP activation, including the α, β and γ subunits of heterotrimeric G proteins. 3 For example, activated Gαs associates with and activates adenylyl cyclase, which catalyzes the release of the secondary messenger cyclic adenosine monophosphate (cAMP). 7 cAMP subsequently activates other proteins including protein kinase A (PKA), which has been shown to stimulate MMP activity. 8 Localized PKA activity in the cell is achieved by more than 50 human PKA-interacting scaffolding proteins, designated A-kinase anchoring proteins (AKAPs), that directly bind PKA and target it to specific subcellular locations. 9 On the other hand, Gαq activates phospholipase C, which cleaves phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG); DAG in turn activates protein kinase C (PKC), which also has been shown to induce MMP-dependent shedding of EGFR ligands. 10 TGFα is one of seven mammalian EGFR ligands that are produced as type 1 transmembrane proteins. [11] [12] [13] In polarized epithelial cells, the TGFα precursor is delivered preferentially to the basolateral cell surface where it undergoes ectodomain cleavage by a selective MMP, a disintegrin and a metalloprotease 17 (ADAM17). This cleavage releases soluble TGFα, which is then rapidly captured by basolateral EGFRs. 14 We previously showed that the protein naked cuticle homolog 2 (NKD2) acts as basolateral sorting adaptor for TGFα. 15 NKD2
coats TGFα-containing exocytic vesicles by interacting directly with the TGFα cytoplasmic domain. These vesicles are then directed to the basolateral surface of polarized epithelial cells where they dock and fuse in a NKD2 myristoylation-dependent manner. 15, 16 NKD2 is a short-lived protein with a half-life of approximately 2 hours and is targeted for degradation by the RING-finger E3 ubiquitin-protein ligase (RNF25). 17 Herein, we have discovered that NKD2 is phosphorylated at serine 223 (S223) after stimulation with GPCR agonists, VIP and PGE 2 , via activation of PKA. NKD2 phosphorylation by PKA is dependent on the molecular scaffold AKAP12. This phosphorylation stabilizes NKD2, promoting efficient cell-surface delivery of TGFα and results in increased EGFR activation. Thus, these studies identify a new mode of GPCR-triggered EGFR transactivation that occurs proximal to MMP cleavage of plasma membrane-anchored ligands.
2 | RESULTS
| PKA phosphorylates NKD2 at S223
Based on our previous results showing that myristoylation and ubiquitylation of NKD2 affect its function, we set out to determine whether NKD2 was also phosphorylated and the possible functional consequence of such phosphorylation. 13, 15, 17 To that end, we labeled MDCK cells stably expressing NKD2-enhanced green fluorescent protein (EGFP) with 32 P-ATP and found that NKD2 was phosphorylated under steady state conditions ( Figure 1A ). To identify potential phosphorylation sites on NKD2, we conducted an in silico protein phosphorylation prediction analysis (NetPhos). 18 Six potential PKA phosphorylation sites (S18, S216, S223, S286, S299 and S337) and 16 potential PKC phosphorylation sites were identified (Table S1) indicating selective phosphorylation at S223 ( Figure 1D ). Of note, NKD2 S223 lies within a consensus pPKA substrate motif (RRPST).
We next generated a phosphorylation-specific polyclonal antibody by immunizing rabbits against the NKD2 phospho-peptide Cell lysates were subjected to NKD2 IP with the R44 antibody against NKD2 and then immunoblotted with pPKA or pPKC substrate motif antibodies, respectively. Membranes were later reprobed with NKD2 to confirm equal loading. As a positive control, AKAP12-EGFP was expressed in the presence or absence of TPA. C, HEK293 cells transiently expressing NKD2-EGFP or NKD1-EGFP were incubated with 1 μM FSK for 5 minutes as indicated. Cell lysates were harvested and subjected to GFP IP, resolved on SDS-PAGE, and probed with GFP, NKD1, NKD2 and pPKA substrate motif antibodies. D, Six serine residues predicted to be PKA phosphorylation sites within NKD2 were mutated individually to alanine (S > A). HEK293 cells transiently expressing EGFP-tagged wild-type (WT) NKD2 and indicated mutants were stimulated with 1 μM FSK for 5 minutes. Cell lysates were harvested and subjected to NKD2 IP, resolved on SDS-PAGE and probed with antibodies against pPKA substrate motif antibody and NKD2. E, HEK293 cells transiently expressing NKD2-EGFP and (S223A)NKD2-EGFP were pretreated with the PKA inhibitor H89 (30 μM, 1 hour) and subsequently incubated with 1 μM FSK for 5 minutes as indicated. Cell lysates were subjected to IP and immunoblotted using the indicated antibodies. F, HEK293 cells transiently expressing NKD2-EGFP were pretreated with H89 (30 μM, 1 hour) as indicated and then stimulated with VIP (100 nM), PGE 2 (100 ng/mL) or carbachol (CCh, 100 μM) for 5 minutes. Cell lysates were subjected to NKD2 IP and immunoblotted using the indicated antibodies. Corresponding total lysates were probed with β-actin antibody as a loading control for (E and F) Figure S2 ). 25 Thus, activation of PKA by the GPCR ligand VIP increases phosphorylation of endogenous NKD2 at the lateral membrane.
| NKD2 S223A mutant exhibits a shorter half-life and results in reduced TGFα delivery to the cell surface
To assess the functional consequence of NKD2 S223 phosphorylation, we first examined its half-life in MDCK cells stably expressing either NKD2-EGFP or (S223A)NKD2-EGFP. Cycloheximide (CHX, 20 μg/mL) was added to block protein synthesis, and cell lysates were prepared and immunoblotted for NKD2 and α-tubulin (as a loading control) at the indicated time points ( Figure 3A ). Over the 8-hour time course, the NKD2 signal persisted longer in cells expressing NKD2-EGFP than (S223A)NKD2-EGFP. These results are quantified on the right in Figure 3B , where half-lives of NKD2-EGFP and (S223A)NKD2-EGFP were determined to be around 2 and 1 hour, respectively. 
| EGFR transactivation by VIP is dependent on NKD2-mediated TGFα delivery
To evaluate how PKA phosphorylation of NKD2 might impact EGFR activity, we took two experimental approaches. In the first approach, we added conditioned medium from MDCK cells transiently expressing TGFα and either wild-type NKD2, (S223A)NKD2, or (G2A)
NKD2 to recipient serum-starved A431 cells. The (G2A)NKD2 mutant cannot be myristoylated, and we have previously shown that this mutation prevents membrane fusion of TGFα-containing NKD2 vesicles. 15, 16 Parenthetically, A431 cells express large amounts of EGFR and are often used to study the effect of EGF-like ligands. 26 Five minutes after addition of conditioned medium, EGFR activity was this signal was equivalent to cells expressing TGFα alone (compare lanes 5 and 6 with lane 8, Figure 4A ). As additional controls, neutralizing antibodies to TGFα or EGFR were added to MDCK cultures 1 hour prior to harvesting of conditioned medium for addition to A431 cells.
The ability of these neutralizing antibodies to block EGFR activity supports that the conditioned medium effects were attributable to TGFα signaling via EGFR ( Figure 4A ). Taken together, these results show that NKD2 regulates the release of soluble, biologically active TGFα.
In the second approach, we added the GPCR ligand VIP to Caco-2 cells cultured on plastic to directly implicate ligand delivery in GPCRmediated EGFR transactivation. Parental Caco-2 cells do not express
TGFα, so we engineered these cells to stably express a doxycyclineinducible TGFα construct (Caco-2 iTGFα). In the uninduced state, addition of VIP to Caco-2 iTGFα cells had no effect on EGFR activity ( Figure 4B, left panel) . However, in the TGFα-induced state, there was a dramatic increase in EGFR activity 1 minute after VIP addition ( Figure 4B , right panel). In these experiments, EGFR activity was monitored by immunblotting EGFR IPs with phospho-tyrosine (pY) antibody. In Figure 4C , we show that VIP-induced EGFR activity was markedly reduced by blocking PKA activity with H89 and blocking metalloprotease activity with BB-94 in Caco-2 iTGFα cells in the induced state. In fact, H89 was at least as effective as BB-94 (compare lanes 4 and 6) in blocking EGFR activity. In a similar experiment, PGE 2 was also able to induce EGFR phosphorylation in a PKA-and TGFα-dependent manner in Caco-2 iTGFα cells ( Figure S3 ). Thus, under these experimental conditions, GPCR transactivation of EGFR is due to increased cell-surface delivery of TGFα.
| AKAP12 interacts with NKD2 and facilitates its phosphorylation by PKA
Localized intracellular PKA activity is achieved by PKA-interacting scaffolding proteins called AKAPs that assemble and compartmentalize multiprotein PKA signaling complexes. 27, 28 AKAP12 was a logical candidate to examine because it was the only AKAP detected in a comprehensive proteomic analysis of NKD2-associated vesicles. 29 Interaction of AKAP12 and PKA has been reported previously. [30] [31] [32] In Figure 5A , we show that NKD2 and AKAP12 interact by reciprocal co-IP in HEK293 cells transiently expressing untagged NKD2 and AKAP12-EGFP. We also show that the two proteins colocalize in cytoplasmic puncta and at the plasma membrane in MDCK cells transiently expressing NKD2-EGFP and AKAP12-mCherry ( Figure 5B ). (CRISPR/Cas9) gene editing; the decrease in AKAP12 was documented by AKAP12 immunoblots in the right two lanes in Figure 5C . Under baseline conditions, pS223-NKD2 was barely detectable in AKAP12 knockout cells and the signal was markedly reduced following FSK stimulation compared to parental HEK293 cells (quantified in Figure 5D ).
| AKAP12 mediates phosphorylation of NKD2 in the cytoplasm
We then examined the ability of FSK and the Gαs-associated GPCR agonists, VIP and PGE 2 , to induce phosphorylation of NKD2 in parental and AKAP12 knockout HEK293 cells. As expected, all three stimuli led to phosphorylation of NKD2 S223 within 30 seconds in parental HEK293 cells ( Figure 6A , left panels). However, in AKAP12 knockout HEK293 cells, these stimuli failed to induce NKD2 S223 phosphorylation ( Figure 6A , right panels). The merged images from the left panels show colocalization (white) of AKAP12 and NKD2 occurring mostly in cytoplasmic puncta. To confirm that AKAP12-mediated phosphorylation of NKD2 occurs in the cytoplasm, we tested whether FSK induced phosphorylation of the myristoylation-defective (G2A)NKD2 mutant. In Figure 6B , we show that FSK increased phosphorylation of (G2A)NKD2 that is restricted to the cytoplasm.
AKAP12 is a dual-specificity AKAP that interacts with both PKA regulatory subunit I (RI) and PKA regulatory subunit II (RII) isoforms of PKA. 33 To determine if this transactivation phenomenon is dependent on RI or RII, we used two stapled peptides, the RI-selective Stapled AKAP Disruptor 2 (RI-STAD-2), and the RII-selective STAD-2. 34, 35 Both of these peptides attenuated FSK-induced NKD2 phosphorylation, indicating both PKA isoforms can phosphorylate NKD2 at S223 ( Figure 6C ). However, the RII-selective STAD-2 had a greater inhibitory effect than RI-specific RI-STAD-2, suggesting a preference for RII in mediating NKD2 phosphorylation (quantified in Figure S4 ).
Thus, AKAP12 is required for GPCR-induced PKA-mediated NKD2 S223 phosphorylation and subsequent TGFα release and EGFR activation.
| DISCUSSION
These studies identify a new mode of GPCR-mediated EGFR transactivation. In classical EGFR transactivation, activation of GPCRs induces MMP-mediated cleavage of membrane-anchored EGFR ligands to release soluble ligands that then bind and activate EGFRs.
We now show that the GPCR ligands VIP and PGE 2 transactivate EGFR by increasing cell-surface delivery of TGFα, a step that precedes ligand cleavage (Figure 4) . Mechanistically, VIP and PGE 2 activate PKA that then phosphorylates NKD2 S223 (Figures 1 and 2 ). This phosphorylation stabilizes NKD2, a selective basolateral sorting adaptor for TGFα; this stabilization of NKD2 enhances delivery of TGFα to the cell surface and results in increased EGFR activation (Figures 3 and 4) . As noted in the introduction, NKD2 is a short-lived protein that is polyubiquitylated in the cytoplasm by the E3 ligase RNF25. 17 It is stabilized by interacting with TGFα in exocytic vesicles that are directed to the basolateral surface of polarized epithelial cells where the vesicles dock and fuse in a NKD2 myristoylation-dependent manner. [15] [16] [17] These effects of NKD2 appear to be selective for TGFα because delivery of two other basolaterally targeted EGFR ligands, amphiregulin and epiregulin, is not impaired in myristoylation-deficient (G2A) NKD2-expressing cells. 36, 37 The present studies were initially designed to determine whether NKD2 was phosphorylated in addition to previously reported ubiquitylation and myristoylation. We show that NKD2 phosphorylation was induced by the PKA agonist FSK but not by the PKC agonist TPA ( Figure 1B and Table S1 ). Moreover, PKA activation selectively phosphorylates NKD2 at S223 (Figure 1D ), resulting in stabilization of NKD2 ( Figure 3A,B) . The half-life of the (S223A)NKD2 mutant is half as long as wild-type NKD2, resulting in less efficient delivery of its cargo TGFα and decreased EGFR activation (Figures 3 and 4) . We also performed experiments with physiological stimuli like the GPCR ligands VIP, PGE 2 and carbachol. VIP and PGE 2 selectively induced NKD2 S223 phosphorylation and subsequent EGFR activation, which could be blocked by the PKA inhibitor H89 ( Figure 1F ). These results show that in addition to inducing cleavage of EGFR ligands, GPCR ligands can enhance NKD2-mediated delivery of TGFα to the cell surface. This new mode of regulation preferentially employs Gαs-associated GPCRs.
It is well established that the localized effects of PKA within the cell are achieved by PKA binding to different AKAPs. As noted above, AKAP12 (alias Gravin or AKAP250) was the only AKAP found in a comprehensive proteomic analysis of NKD2-associated vesicles. 29 AKAP12
is found in multiple cellular compartments, including the plasma membrane, cytosol, and nucleus, and it has been assigned specific roles in each of these compartments. 38 AKAP12 has been touted to be a tumor suppressor, and even more specifically, a metastasis suppressor;
Gelman and coworkers identified AKAP12 as a gene downregulated by v-Src and named Src-Suppressed C Kinase Substrate (SScCKS) and given the moniker "essex." 32, 39 A number of functional domains have been identified in AKAP12, including a second residue glycine that is myristoylated. 40 AKAP12 associates with both PKA and PKC. Grove and coworkers reported that activation of PKC redistributes AKAP12 from the plasma membrane to punctate perinuclear vesicles, leading these investigators to speculate that it represents an example of PKC and PKA crosstalk. 41 Under our experimental conditions, TPA activation of PKC did not result in phosphorylation of NKD2, but FSK activation of PKA resulted in phosphorylation of S223 NKD2 ( Figure 1B) . Importantly, we showed AKAP12 interacts with NKD2 and that this interaction occurs within specific subcellular locations in the cell ( Figures 5A,B and 6A,B). Finally, AKAP12 knockout abrogated baseline phosphorylation of S223 NKD2 and attenuated S223 NKD2 phosphorylation induced in response to FSK, VIP and PGE 2 ( Figure 6A ).
Because GPCR transactivation of EGFR was discovered over 20 years ago, it has become a well-accepted, clinically relevant biological phenomenon that has been extended to multiple diverse stimuli 
| MATERIALS AND METHODS

| Plasmids, antibodies and other reagents
The construction and expression of human NKD2 (NP_149111.1) fused with EGFP has been previously described. 15 All NKD2 site mutants were generated either by Stratagene's quick change site-directed mutagenesis kit or by polymerase chain reaction (PCR) overlap extension. 
| Statistics
Statistical analyses were performed using GraphPad Prism software (version 7.02; GraphPad Software, Inc.). All measurements were normalized to the highest value and plotted as mean ± SD. Significance determination was performed by ordinary one-way analysis of variance followed by Tukey's multiple comparisons test, with a single pooled variance; P < 0.05 was considered statistically significant between the pairs tested. 
